We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BXP icon
476
Boston Properties
BXP
$11.2B
$1.71M 0.03%
15,181
-114
-0.7% -$13.8K
VRSN icon
477
VeriSign
VRSN
$25.4B
$1.68M 0.03%
11,302
-12,117
-52% -$1.82M
VTR icon
478
Ventas
VTR
$47.7B
$1.67M 0.03%
28,563
+1,030
+4% +$60.7K
PAYX icon
479
Paychex
PAYX
$42.3B
$1.67M 0.03%
25,632
+790
+3% +$53.5K
BBY icon
480
Best Buy
BBY
$18.9B
$1.67M 0.03%
31,436
+3,670
+13% +$240K
AKBA icon
481
Akebia Therapeutics
AKBA
$341M
$1.66M 0.03%
300,000
+230,000
+329% +$1.8M
SLF icon
482
Sun Life Financial
SLF
$46.6B
$1.66M 0.03%
50,028
+3,225
+7% +$117K
PBA icon
483
Pembina Pipeline
PBA
$29B
$1.65M 0.03%
55,540
+231
+0.4% +$7.66K
WY icon
484
Weyerhaeuser
WY
$17.7B
$1.64M 0.03%
75,034
+17,003
+29% +$453K
NTLA icon
485
Intellia Therapeutics
NTLA
$1.52B
$1.64M 0.03%
120,000
– –
FRC
486
DELISTED
First Republic Bank
FRC
$1.63M 0.03%
18,782
-1,204
-6% -$110K
CDW icon
487
CDW
CDW
$18.4B
$1.62M 0.02%
19,962
+7,345
+58% +$633K
WCN
488
Waste Connections
WCN
$42.7B
$1.61M 0.02%
21,651
-3,306
-13% -$252K
CLX icon
489
Clorox
CLX
$12.1B
$1.6M 0.02%
10,358
-1,191
-10% -$186K
MEOH icon
490
Methanex
MEOH
$4.12B
$1.59M 0.02%
33,072
+3,610
+12% +$225K
MLAB icon
491
Mesa Laboratories
MLAB
$559M
$1.55M 0.02%
7,425
+225
+3% +$43.9K
O icon
492
Realty Income
O
$61.3B
$1.54M 0.02%
25,288
-2,580
-9% -$154K
ESIO
493
DELISTED
Electro Scientific Industries
ESIO
$1.54M 0.02%
+51,378
New +$1.28M
ESS icon
494
Essex Property Trust
ESS
$18.9B
$1.53M 0.02%
6,238
+681
+12% +$172K
VNO icon
495
Vornado Realty Trust
VNO
$7.54B
$1.53M 0.02%
24,668
+1,841
+8% +$126K
ALLY icon
496
Ally Financial
ALLY
$13.4B
$1.5M 0.02%
66,348
+14,470
+28% +$362K
CNC icon
497
Centene
CNC
$31.6B
$1.5M 0.02%
25,944
-4,436
-15% -$297K
VRSK icon
498
Verisk Analytics
VRSK
$27.8B
$1.49M 0.02%
13,639
+9,818
+257% +$1.15M
DLR icon
499
Digital Realty Trust
DLR
$71.5B
$1.49M 0.02%
13,948
– –
CTAS icon
500
Cintas
CTAS
$86B
$1.48M 0.02%
35,312
+5,840
+20% +$261K
18 19
20
21 22

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.